Erythropoiesis-Stimulating Agent (ESA) - Medical Benefit Preferred Physician-Administered Drug Exceptions Criteria
Customize your policy alerts
Sign up for Oscar Health Policy CG084 alerts
Get alerted when Policy CG084 changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization exceptions for non-preferred, physician-administered erythropoiesis-stimulating agents under the medical benefit when preferred products cannot be used, subject to clinical documentation, medical necessity, applicable law, and member benefit terms.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.